ATLN vs MAMK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 2/9, indicating severe operational and financial distress. Despite a recent short-term price surge of +199.2% over one month, the company remains deeply unprofitable with negative margins across all key metrics, including a -22.66% profit margin and -16.64% ROA. Valuation metrics are distorted by negative book value (Price/Book: -9.75), and the lack of Altman Z-Score due to structural issues suggests potential bankruptcy risk. While the sector peers show mixed performance, ATLN’s fundamentals and deteriorating earnings trajectory—missing estimates by -11.1%—undermine any sustainable recovery case.
MAMK exhibits a dangerous decoupling between its market price and fundamental value, evidenced by a Piotroski F-Score of 5/9 (Stable) but a Graham Number of only $1.00 against a current price of $13.16. While revenue growth is impressive at 43.70%, the company is barely profitable with a profit margin of 0.01% and a negative operating margin. The extreme P/E ratio of 219.33 and Price/Book of 17.81 suggest a speculative bubble rather than value creation. Despite a healthy balance sheet (low debt, high current ratio), the intrinsic value of $0.42 indicates the stock is severely overvalued.
Compare Another Pair
Related Comparisons
ATLN vs MAMK: Head-to-Head Comparison
This page compares Atlantic International Corp. (ATLN) and MaxsMaking Inc. (MAMK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.